112 related articles for article (PubMed ID: 7993808)
1. Sequential relapses of blastic crisis may involve different clones of cells with different molecular abnormalities.
Foti A; Cline MJ
Br J Haematol; 1994 Jul; 87(3):627-30. PubMed ID: 7993808
[TBL] [Abstract][Full Text] [Related]
2. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.
Foti A; Ahuja HG; Allen SL; Koduru P; Schuster MW; Schulman P; Bar-Eli M; Cline MJ
Blood; 1991 Jun; 77(11):2441-4. PubMed ID: 2039825
[TBL] [Abstract][Full Text] [Related]
3. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
4. Double P53 point mutation in extramedullary blast crisis of chronic myelogenous leukemia.
Marasca R; Longo G; Luppi M; Barozzi P; Torelli G
Leuk Lymphoma; 1994 Dec; 16(1-2):171-5. PubMed ID: 7696924
[TBL] [Abstract][Full Text] [Related]
5. Multiple aberrant splicing of the p53 transcript without genomic mutations around exon-intron junctions in a case of chronic myelogenous leukaemia in blast crisis: a possible novel mechanism of p53 inactivation.
Nakai H; Kaneko H; Horiike S; Ariyama Y; Misawa S; Kashima K; Ishizaki K
Br J Haematol; 1994 Aug; 87(4):839-42. PubMed ID: 7527245
[TBL] [Abstract][Full Text] [Related]
6. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.
Schütte J; Opalka B; Becher R; Bardenheuer W; Szymanski S; Lux A; Seeber S
Leuk Res; 1993 Jun; 17(6):533-9. PubMed ID: 8505851
[TBL] [Abstract][Full Text] [Related]
8. Correlation of M-bcr breakpoint with different chromosomal abnormalities in blast crisis Ph1-positive CML.
Mills KI; Stewart J; Burnett AK
Leuk Res; 1991; 15(11):999-1003. PubMed ID: 1961015
[TBL] [Abstract][Full Text] [Related]
9. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
[TBL] [Abstract][Full Text] [Related]
11. Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis.
Guinn BA; Smith M; Padua RA; Burnett A; Mills K
Leuk Res; 1995 Aug; 19(8):519-25. PubMed ID: 7658697
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
[TBL] [Abstract][Full Text] [Related]
13. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
14. A clone with a chromosome abnormality, i(17q), in the myeloid crisis of chronic myeloid leukemia is able to differentiate into neutrophil, basophil and eosinophil lineages.
Yokota S; Okuda T; Sonoda Y; Maekawa T; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1988 Dec; 18(4):321-6. PubMed ID: 3204681
[TBL] [Abstract][Full Text] [Related]
15. Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML.
Guerrasio A; Martinelli G; Ambrosetti A; Falda M; Paolino F; Rege-Cambrin G; Rosso C; Pignatti PF; Gasparini P; Perona G
Haematologica; 1991; 76(2):126-30. PubMed ID: 1937170
[TBL] [Abstract][Full Text] [Related]
16. Myelomonocytic crisis with t(5;17) and a p53 mutation in a patient with chronic myelogenous leukemia.
Nakagawa H; Fujii H; Nakai H; Inazawa J; Misawa S
Am J Hematol; 1994 Apr; 45(4):335-40. PubMed ID: 8178805
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia.
Gaidano G; Serra A; Guerrasio A; Rege-Cambrin G; Mazza U; Saglio G
Ann Hematol; 1994 Jan; 68(1):3-7. PubMed ID: 8110876
[TBL] [Abstract][Full Text] [Related]
18. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia.
González FA; Villegas A; Ferro MT; Cabello P; Morales D; Perez J; Martinez R
Br J Haematol; 1993 Jun; 84(2):351-2. PubMed ID: 8398844
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis.
Asou H; Eguchi M; Suzukawa K; Morishita K; Tanaka K; Date M; Hamamoto K; Kamada N
Br J Haematol; 1996 Apr; 93(1):68-74. PubMed ID: 8611478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
